Dexcom · 16 hours ago
Engineering Technician 3-Monday-Friday (9:00AM-5:00PM)
Dexcom Corporation is a pioneer and global leader in continuous glucose monitoring (CGM), aiming to improve health outcomes through innovative technology. The Engineering Technician 3 will work with a team to manufacture prototype sensors, perform maintenance on equipment, and maintain laboratory documentation.
DiabetesHealth DiagnosticsMedical DeviceSensor
Responsibilities
You work with Senior Scientists, Engineers and a team of Technicians to manufacture functional prototype sensors for cutting edge future product designs
You perform troubleshooting and preventative maintenance for instruments and equipment, as well as setup/teardown activities daily
You perform laboratory-related clerical duties including filing, recordkeeping, entering data into computer database, and documenting experimental results when necessary
You manufacture sensor probes, utilizing a variety of released, off-the-shelf, and in-development equipment. (e.g. laser singulation and coating equipment)
You maintain a clean working environment and help keep track of existing sensor and material inventory
Qualification
Required
Typically requires a minimum of 4-6 years of related experience
High School diploma/certificate or equivalent
Benefits
A full and comprehensive benefits program.
Growth opportunities on a global scale.
Access to career development through in-house learning programs and/or qualified tuition reimbursement.
Company
Dexcom
Dexcom develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management.
H1B Sponsorship
Dexcom has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (54)
2024 (41)
2023 (67)
2022 (75)
2021 (49)
2020 (36)
Funding
Current Stage
Public CompanyTotal Funding
$2.16BKey Investors
RWI Group
2023-05-02Post Ipo Debt· $1B
2020-05-12Post Ipo Debt
2018-11-01Post Ipo Equity· $750M
Leadership Team
Recent News
2026-01-16
Medical Device Network
2026-01-15
Company data provided by crunchbase